TC BioPharm (Holdings) plc American Depositary Shares
TCBP
TCBP was delisted on the 21st of March, 2025.
3 hedge funds and large institutions have $141K invested in TC BioPharm (Holdings) plc American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
15% less capital invested
Capital invested by funds: $166K → $141K (-$25K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$56.4K |
| 2 |
VF
Virtu Financial
New York
|
+$56.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$56.4K |
| 2 |
KC
KCL Capital
New York
|
-$37K |
TCBP Hedge Fund Activity: Q3 2022 in Review
3 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q3 2022, worth a combined $141K — down 15% from $166K a quarter earlier.
Fund positioning in TCBP was balanced in Q3 2022: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $56.4K. The largest seller was Warberg Asset Management, exiting entirely with an estimated $56.4K sold.
- 3 institutional investors held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $141K of TC BioPharm (Holdings) plc American Depositary Shares stock for Q3 2022, down 15% quarter-over-quarter.
- 2 funds opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q3 2022 and 2 closed out, a net change of 0 holders.
- The largest TC BioPharm (Holdings) plc American Depositary Shares buyer in Q3 2022 was Renaissance Technologies, an estimated $56.4K added.
- The largest TC BioPharm (Holdings) plc American Depositary Shares seller in Q3 2022 was Warberg Asset Management, an estimated $56.4K sold.
Based on aggregated 13F filings for Q3 2022.